|
NUP214 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.558600E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.978200E-03 |
| Normal-vs-Stage2 |
6.698200E-02 |
| Normal-vs-Stage3 |
3.618400E-03 |
| Normal-vs-Stage4 |
4.136300E-03 |
| Stage1-vs-Stage2 |
6.096400E-01 |
| Stage1-vs-Stage3 |
5.273600E-01 |
| Stage1-vs-Stage4 |
2.678800E-01 |
| Stage2-vs-Stage3 |
3.275400E-01 |
| Stage2-vs-Stage4 |
1.154600E-01 |
| Stage3-vs-Stage4 |
4.684200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.078900E-03 |
| Normal-vs-AfricanAmerican |
1.326320E-02 |
| Normal-vs-Asian |
2.467900E-02 |
| Caucasian-vs-AfricanAmerican |
9.550800E-01 |
| Caucasian-vs-Asian |
3.171600E-01 |
| AfricanAmerican-vs-Asian |
2.626200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.436300E-03 |
| Normal-vs-Female |
3.943800E-02 |
| Male-vs-Female |
9.492000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.618800E-03 |
| Normal-vs-Extreme_Weight |
1.917080E-03 |
| Normal-vs-Obese |
1.692240E-01 |
| Normal-vs-Extreme_Obese |
3.479700E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.568600E-01 |
| Normal_Weight-vs-Obese |
1.867830E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.516600E-01 |
| Extreme_Weight-vs-Obese |
1.327990E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.250800E-01 |
| Obese-vs-Extreme_Obese |
2.206200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.415600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.329760E-01 |
| Normal-vs-Age(61-80Yrs) |
8.815800E-04 |
| Normal-vs-Age(81-100Yrs) |
1.427740E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.113400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.322400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.519200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.037400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.121850E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.933600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.970570E-01 |
| Normal-VS-Type2 PRCC |
2.52130000000239E-06 |
| Normal-VS-KIRP CIMP |
1.862070E-02 |
| Normal-VS-Unclassified PRCC |
1.116080E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.27310000000536E-06 |
| Type1 PRCC-VS-KIRP CIMP |
1.023150E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.410400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.766600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.672300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.837000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.381700E-04 |
| Normal-vs-N1 |
8.432300E-02 |
| Normal-vs-N2 |
6.409700E-02 |
| N0-vs-N1 |
3.309000E-01 |
| N0-vs-N2 |
6.114800E-01 |
| N1-vs-N2 |
4.323400E-01 |
|
|
